In The News

• February 27, 2012
  "Switching Study Required for Biosimilar Interchangeability Draws Questions"
  Inside Health Reform
  D. Christopher Ohly
  Schiff Hardin partner Chris Ohly is extensively quoted in this article on the failure of FDA guidelines for biosimilar pharmaceuticals to address interchangeability. Mr. Ohly commented that, based on the FDA's limited comments in the recently released guidelines and other data, cross-over studies may well be required to establish interchangeability of a biosimilar product. He noted that the FDA said it is unlikely to approve a biosimilar as an interchangeable product based on an original application.
• February 13, 2012
  "New Biosimilar Path Is Anything But Predictable"
  BioWorld Today
  D. Christopher Ohly
  This article about recent guidance from the U.S. Food and Drug Administration on biosimilar drug development quotes Schiff Hardin partner Chris Ohly. Mr. Ohly, who focuses on pharmaceutical industry issues in the firm's Intellectual Property Group, notes that the guidance could encourage companies previously considering biosimilar development to proceed along that path.
• February 10, 2012
  "Biosimilar Guidance Silent on Industry's Biggest Questions"
  Law360
  D. Christopher Ohly
  Schiff Hardin partner Chris Ohly is quoted in this article about new guidance from the U.S. Food and Drug Administration regarding the development of generic versions of biological drugs. Mr. Ohly, a partner in the firm's Intellectual Property Group, points out that the guidance contains no information about clinical trial requirements or interchangeability, two factors that will greatly affect biosimilar development costs.
• February 1, 2012
  'Fresh from the biotech pipeline ? 2011'
  Nature Biotechnology
  D. Christopher Ohly
  This article about the U.S. FDA approval process for biosimilar drugs quotes Schiff Hardin partner Chris Ohly. Mr. Ohly, who focuses on pharmaceuticals in the firm's Intellectual Property Group, comments that companies moving through the biosimilar and interchangeable drug approval process may end up innovating their products as a result.
• January 27, 2012
  "A Timely Reminder that MPAA and RIAA Shouldn't Be Trusted with Too Much Enforcement Power"
  Forbes
  David Jacoby, Judith S. Roth
  This article about the recently defeated Stop Online Piracy Act and similar efforts by Congress to enforce copyright protection online quotes Schiff Hardin's David Jacoby and Judith Roth. Mr. Jacoby and Ms. Roth, of the firm's Intellectual Property Group, comment on the difficulties of addressing copyright issues on the Internet.
• January 27, 2012
  "BIO Vows to Protect Biosimilar Provisions from Health Reform Repeal Efforts"
  FDA Week
  D. Christopher Ohly
  Schiff Hardin partner Chris Ohly is quoted in this article about the potential severability of the Biosimilars Act from the Affordable Care Act in a forthcoming decision by the Supreme Court in litigation attacking the ACA's "individual mandate." He commented about possible turmoil in the generic pharmaceutical industry if the Affordable Care Act is overturned as a whole by the Court. Mr. Ohly, a partner in the firm's Intellectual Property Group, pointed out that the "individual mandate" is completely unrelated to the Biosimilars Act. He added that the Biosimilars Act can be readily severed from the rest of the health care reform law without difficulty and in a manner consistent with the Court's prior decisions about severability.
• April 25, 2011
  "Patents on the line"
  BioCentury
  D. Christopher Ohly
  In this article about challenges in the Supreme Court to patent protections, Schiff Hardin partner Chris Ohly is quoted regarding the standards used to invalidate a patent.
• February 11, 2011
  "Patent reform looks likely to pass this year"
  BioPharm Insight
  D. Christopher Ohly
  Schiff Hardin's Christopher Ohly, a partner in the firm's Intellectual Property group, is quoted in this pharmaceutical news service story on patent reform legislation. Mr. Ohly points out likely consequences of the legislation, including the significant change to first-to-file priority in patent applications.
• February 10, 2011
  'Q and A With Schiff Hardin's Stephen Hankins'
  Law360
  Stephen M. Hankins
  The Law360 newswire conducted a detailed interview with Schiff Hardin partner and executive committee member Stephen Hankins, leader of the firm's Intellectual Property group. The piece covers topics including where Mr. Hankins finds challenge and reward in the legal profession, reforms needed in patent law, and advice to new lawyers starting their careers in IP litigation.
• September 29, 2009
  'Add Knockoff Bags to Web Hosts' Woes'
  National Law Journal
  David Jacoby
  This article about a $32 million judgment against two Web hosting firms for contributory trademark infringement, in the form of counterfeit handbag sales, quotes Schiff Hardin partner David Jacoby. Mr. Jacoby comments on the responsibility of Web site hosting companies when fake brand-name goods are being sold online using their services.
• September 15, 2009
  'Twitter Sued Over User Posing As Energy Co. Oneok'
  Law360
  David Jacoby, Judith S. Roth
  This article, on a trademark infringement claim against the social networking site Twitter by an Oklahoma energy company, quotes Schiff Hardin attorneys Judith Roth and David Jacoby. Ms. Roth and Mr. Jacoby comment on the significance of the case, in which a Twitter user adopted the company's name, in the evolving 'Wild, Wild West' world of IP in the online realm.
• September 8, 2009
  'The Little Indian Restaurant That Could'
  The AmLaw Daily
  David Jacoby, Judith S. Roth
  Malaysian courts turned down McDonald's bid in a trademark infringement suit to stop a competing restaurant from calling itself McCurry. The AmLaw Daily reached out to Schiff Hardin IP attorneys David Jacoby and Judith Roth for a quick Q&A on the significance of the ruling. The published interview draws on their experience protecting the rights of varied trademark holders, and discusses why major brand owners need to be proactive in protecting their rights and some of the practical aspects of doing so.
• July 21, 2009
  'Michael Jackson's estate: the fallout will be monumental'
  Gannett News Service, including USA Today
  David Jacoby
  David Jacoby, a partner focusing on intellectual property in Schiff Hardin's New York office, is quoted in this article about Michael Jackson's estate, and the continuing marketing value of the entertainer's image.
• June 29, 2009
  'Estate fallout will be monumental: It could take years to sort it all out, legal experts say'
  USA Today
  David Jacoby
  Schiff Hardin partner David Jacoby, based in the firm's New York office, is quoted in this USA Today piece on the ways in which Michael Jackson's estate and control of rights to his image may be handled following his death on June 25.
• February 1, 2009
  'IP Does Not Mean Insane Profit'
  ABA Journal
  Sailesh K. Patel
  Schiff Hardin partner Sailesh Patel, who focuses on pharmaceutical and chemical patent litigation, is quoted in this article that discusses the challenges of integrating a full-service intellectual property practice into a general firm model.
• September 15, 2008
  'The NLJ Client List: Who Represents Corporate America'
  National Law Journal
  Schiff Hardin’s name appears several times in this 21st annual survey of go-to law firms for the nation’s largest companies. These Fortune 100 companies rely on Schiff Hardin’s representation in matters ranging from intellectual property work to torts and negligence to commercial law and contracts litigation.
• August 3, 2007
  'Debate Rages Over IP Protection in Fashion Industry'
  IP Law 360
  Judith S. Roth
  In this article about copyright law and the fashion industry Schiff Hardin partner Judith Roth offers her insights on recent high-profile intellectual property lawsuits.
• July 1, 2007
  'Fair Deal'
  AmericanWay
  David Jacoby
  David Jacoby, a partner in Schiff Hardin’s New York office, weighs in on the topic of fair-trade clothing in this article about a growing sector of the apparel industry.
• May 1, 2007
  'Trial Lawyer Finds Success Inside And Outside The Courtroom'
  Chicago Lawyer
  Roger Pascal
  This three-page feature article spotlighted Roger Pascal’s illustrious 40+ years career as an attorney and also highlighted his many pro bono and charitable activities. This news story included a focus on his volunteer work for LifeLine Pilots, which transports patients for ongoing medical treatments through licensed private pilots such as Mr. Pascal donating flight expenses and time.
• November 20, 2006
  'On The Move'
  Washington Legal Times
  D. Christopher Ohly
  D. Christopher Ohly was featured in this daily column that spotlighted his intellectual property practice and his move to Schiff Hardin’s expanding Washington, D.C. office.